Chicago, IL – July 18, 2011 – Nitin Jain joins Cancer Treatment Centers of America (CTCA) to lead engagement with cancer patients and enhance their relationship with CTCA. Jain, who has an extensive background in the development of online business strategies, will become vice president of engagement at CTCA. In this capacity he will be responsible for enhancing and expanding the organization’s current digital presence and value proposition.
CTCA is a national network of destination hospitals, specializing in treating complex and advanced-stage cancers. Cancer patients and their families travel on average more than 300 miles to treat at one of the four CTCA hospitals located in Chicago, Philadelphia, Phoenix and Tulsa.
For nearly 30 years, CTCA has offered a “whole person” approach to cancer care, combining conventional clinical treatments and technologies for fighting cancer along with scientifically-supported complementary therapies to help mitigate the side effects of treatment and maintain the immune system to improve each patient’s quality of life.
Jain was most recently with US Oncology in Houston, TX, where he served in multiple business leadership roles during the past four years. During his tenure he headed corporate development and strategy and, most recently, was general manager of US Oncology’s web portals. Prior to that he served as a corporate development principal for Sabre, the parent company of Travelocity, and as an operations consultant for Accenture. Nitin holds an M.S. from Purdue University and an MBA from the University of Chicago.
“CTCA is a market leader in delivering superior clinical outcomes as well as unparalleled patient experience,” said Jain. “Its unique Patient Empowered Care model is very impressive, and that’s what attracted me to CTCA. Being ‘patient-centered’ is a buzz phrase today, but CTCA has been delivering on that promise for many years as reflected in their consistently high patient satisfaction scores. And I’m very excited about the opportunity to explore new ways to connect with patients, their families, and caregivers to help them understand the value of CTCA and how our clinical experts might help them today.”
The CTCA approach to care is based on the organization’s Mother Standard® of care. The Mother Standard is a cultural organization principle that each CTCA clinician and support team member embraces to provide care based on what they’d want for their own mother. CTCA then uses continuous process improvement programs like LEAN and Six Sigma to create one of the most efficient cancer care experiences available.
Peter Yesawich, CTCA chief growth officer said Jain will bring new leadership and insights to an already successful online engagement team. “Nitin will be a great addition to our team, and together we’ll discover new and meaningful ways to engage cancer patients and their families. Cancercenter.com is one of the top cancer hospital web sites in the country, visited by more than seven million people every year, and Nitin’s leadership will help us expand our web presence in an effective and engaging manner and share the information patients need to be empowered.”
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based complementary therapies that support patients physically and emotionally, enhancing their quality of life while reducing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.